For Brilliant Color: Packaging the First LSD Blotter

Blotter art, history, and culture

  • Commenters connect the article to LSD blotter as visual art, including large private collections and institutional projects documenting designs.
  • Some note the cleverness of the Kodachrome parody packaging and speculate about whether it’s parodying commercial “scientific product” language.
  • Side discussions mention psychedelic music, the historical role of LSD in early Silicon Valley, and puns like “Psychedelicatessen.”

Legal constraints and research

  • Several argue the “War on Drugs” and UN conventions, heavily driven by US policy, effectively chilled psychedelic research worldwide for decades.
  • Others counter that modern research has restarted at major US institutions over the last ~20 years and that dismissing the field as “nonsense” ignores a growing peer‑reviewed literature.

Therapeutic and cognitive effects

  • Some point to studies on psychedelics for anxiety, depression, PTSD, addiction, and end‑of‑life distress, and note FDA “breakthrough therapy” status for some uses.
  • Others emphasize the lack of strong, objective evidence that LSD boosts intelligence, creativity, or work performance, and note it doesn’t appear in “doping” cultures like stimulants do.
  • There’s debate over “neuroplasticity”: psychedelics may increase it, but one commenter quotes a researcher asking “who says plasticity is good?”

Creativity, consciousness, and self‑report

  • Many stress that creativity and consciousness are hard to measure; effects may be indirect and long‑term, more like travel or profound life experiences.
  • Skeptics highlight self‑delusion and mediocre output despite users’ belief in “breakthroughs,” and question grand claims about “higher realities.”
  • Others argue the main value is subjective insight, altered perspective, and emotional processing, not productivity gains.

Experiences, set & setting, and integration

  • Multiple users describe LSD and other psychedelics as powerful but unpredictable experiences, strongly dependent on mindset, environment, dose, and “integration” afterward.
  • Some portray LSD as mostly recreational or empathogenic; others describe deep introspection, ego dissolution, and lasting attitude shifts (e.g., reduced prejudice).

Risks, mental health, and bad outcomes

  • Numerous warnings: bad trips can be among the worst experiences of one’s life; psychedelics can exacerbate or unmask psychosis, especially schizophrenia‑spectrum vulnerabilities.
  • Several report friends or relatives developing severe mental illness or dying after heavy use; others say their own use was benign but still wouldn’t recommend it casually.
  • There’s explicit pushback against “cure‑all” hype; people stress screening for mental illness, careful dosing, and having support or sedatives available.

Practicalities: dosing, testing, and access

  • Technical discussion touches on microgram‑level potency, blotter dosing methods, uneven distribution if sheets are soaked, and difficulty of detecting LSD in standard urine tests.
  • Commenters note LSD’s legal status leads to purity issues (e.g., dangerous analogs) and wish for regulated, legal access to reduce substitution risk.